Investigator Sponsored Research (ISR) — Internal Medicine areas of interest

About this program

Pfizer's Investigator-Sponsored Research (ISR) program invites qualified investigators in Internal Medicine to submit proposals seeking company support (e.g., funding and/or drug supply) for studies in priority areas including cardiovascular disease, migraine (rimegepant; zavegepant U.S. only), nonalcoholic steatohepatitis (NASH), and obesity. Applications must be submitted during Pfizer's posted application and batched review cycles and follow the guidance at www.pfizer.com/ISR; submissions are reviewed by Pfizer Global Reviewers and any support is contingent on approval and execution of a research agreement. Eligible applicants are qualified researchers at appropriate institutions who should note that proposal submission does not guarantee funding and may direct inquiries to GlobalMedicalGrants@pfizer.com.